Ocular Therapeutix, Inc (OCUL) stock
OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$6.02+0.01 (+0.17%)
Close on Nov 17, 2026Market cap $1.32BP/E –Yield –
Ocular Therapeutix price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ocular Therapeutix's price to book ratio was 2.8× on Nov 11, 2026, against 8.2× a year earlier. Over the last 5 years it ranged from 2.2× to 97.0×, with a median of 4.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.8× | −5.4 |
| 2025 | Dec 31, 2025 | 8.2× | +4.4 |
| 2024 | Dec 31, 2024 | 3.8× | −41.3 |
| 2023 | Dec 29, 2023 | 45.1× | +40.4 |
| 2022 | Dec 30, 2022 | 4.7× | −1.4 |
| 2021 | Dec 31, 2021 | 6.1× | −105.8 |
| 2020 | Oct 30, 2020 | 111.9× | +95.1 |
| 2019 | Dec 31, 2019 | 16.8× | +13.3 |
| 2018 | Dec 31, 2018 | 3.5× | −0.1 |
| 2017 | Dec 29, 2017 | 3.6× | +0.3 |
| 2016 | Dec 30, 2016 | 3.3× | +1.0 |
| 2015 | Dec 31, 2015 | 2.3× | −5.3 |
| 2014 | Dec 31, 2014 | 7.6× | – |
See a number that looks wrong?